AG真人官方

STOCK TITAN

Nanalysis Announces Second Quarter 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Nanalysis Scientific Corp. (OTCQX: NSCIF) reported challenging Q2 2025 results marked by a 17% decline in total revenue to $9.6 million. Product sales dropped significantly by 46% to $2.9 million, while security services revenue increased by 7% to $5.6 million.

Despite revenue challenges, the company achieved notable improvements in product sales gross margins, increasing to 61% from 50% year-over-year. The company reported an Adjusted EBITDA loss of $462,000 compared to a profit of $759,000 in Q2 2024, and a net loss of $2.1 million.

Key developments include closing a $2 million promissory note financing, implementing efficiency measures in security services, and securing loan amendments to reduce principal payments through April 2026.

Nanalysis Scientific Corp. (OTCQX: NSCIF) ha comunicato risultati difficili per il secondo trimestre 2025, con un calo del 17% dei ricavi totali a 9,6 milioni di dollari. Le vendite di prodotti sono diminuite in modo marcato, del 46% a 2,9 milioni, mentre i ricavi dai servizi di sicurezza sono aumentati del 7% a 5,6 milioni.

Nonostante la flessione dei ricavi, l'azienda ha migliorato significativamente i margini lordi sulle vendite di prodotti, saliti al 61% dal 50% rispetto a un anno prima. Ha riportato un Adjusted EBITDA negativo di 462.000 dollari rispetto a un utile di 759.000 dollari nel Q2 2024 e una perdita netta di 2,1 milioni.

Tra gli sviluppi principali figurano la chiusura di un finanziamento tramite cambiale da 2 milioni di dollari, l'attuazione di misure di efficienza nei servizi di sicurezza e la concessione di emendamenti ai prestiti per ridurre i pagamenti del capitale fino ad aprile 2026.

Nanalysis Scientific Corp. (OTCQX: NSCIF) present贸 unos resultados complicados en el segundo trimestre de 2025, con una ca铆da del 17% en los ingresos totales hasta 9,6 millones de d贸lares. Las ventas de productos se redujeron considerablemente, un 46% hasta 2,9 millones, mientras que los ingresos por servicios de seguridad aumentaron un 7% hasta 5,6 millones.

A pesar de los retos en los ingresos, la compa帽铆a mejor贸 de forma notable los m谩rgenes brutos de las ventas de productos, que subieron al 61% desde el 50% interanual. Registr贸 un EBITDA ajustado negativo de 462.000 d贸lares frente a un beneficio de 759.000 d贸lares en el Q2 de 2024 y una p茅rdida neta de 2,1 millones.

Entre los hitos clave est谩n el cierre de un financiamiento mediante pagar茅 de 2 millones de d贸lares, la implementaci贸n de medidas de eficiencia en los servicios de seguridad y la obtenci贸n de enmiendas a pr茅stamos para reducir los pagos del capital hasta abril de 2026.

Nanalysis Scientific Corp. (OTCQX: NSCIF)電� 2025雲� 2攵勱赴鞐� 鞏措牑鞖� 鞁れ爜鞚� 氚滍憸頄堨溂氅�, 齑濍Г於滌澊 17% 臧愳唽頃� 960毵� 雼煬毳� 旮半頄堨姷雼堧嫟. 鞝滍拡 韺愲Г電� 搿� 韥矊 欷勳棃瓿�, 氤挫晥 靹滊箘鞀� 毵れ稖鞚 7% 歃濌皜頃� 560毵� 雼煬毳� 旮半頄堨姷雼堧嫟.

毵れ稖 鞎呿檾鞐愲弰 攵堦惮頃橁碃 鞝滍拡 毵れ稖 齑濍歆勳潃 鞝勲厔 雽牍� 50%鞐愳劀 61%搿� 雽韽� 臧滌劆霅橃棃鞀惦媹雼�. 須岇偓電� 臁办爼 EBITDA 靻愳嫟 46毵�2觳� 雼煬毳� 旮半頄堨溂氅�, 鞚措姅 2024雲� 2攵勱赴鞚� 75毵�9觳� 雼煬 鞚挫澋瓿� 牍勱祼霅╇媹雼�. 靾滌啇鞁れ潃 210毵� 雼煬鞓赌鞀惦媹雼�.

欤检殧 靷暛鞙茧電� 200毵� 雼煬 鞎届啀鞏挫潓(頂勲氙胳劀毽吀韸�) 鞛愱笀 臁半嫭 毵堦皭, 氤挫晥 靹滊箘鞀れ潣 須湪靹� 鞝滉碃 臁办箻 鞁滍枆, 攴鸽Μ瓿� 2026雲� 4鞗旉箤歆 鞗愱笀 靸來櫂鞚� 欷勳澊旮� 鞙勴暅 雽於� 靾橃爼 瓿勳暯 觳搓舶 霌膘澊 鞛堨姷雼堧嫟.

Nanalysis Scientific Corp. (OTCQX: NSCIF) a publi茅 des r茅sultats difficiles pour le 2e trimestre 2025, avec une baisse de 17% du chiffre d'affaires total 脿 9,6 millions de dollars. Les ventes de produits ont chut茅 de mani猫re significative, de 46% 脿 2,9 millions, tandis que les revenus des services de s茅curit茅 ont augment茅 de 7% 脿 5,6 millions.

Malgr茅 la pression sur les revenus, la soci茅t茅 a nettement am茅lior茅 les marges brutes sur les ventes de produits, qui sont pass茅es 脿 61% contre 50% sur un an. Elle a enregistr茅 une perte d'EBITDA ajust茅 de 462 000 dollars contre un b茅n茅fice de 759 000 dollars au T2 2024, et une perte nette de 2,1 millions.

Parmi les faits marquants figurent la cl么ture d'un financement par billet 脿 ordre de 2 millions de dollars, la mise en place de mesures d'efficacit茅 pour les services de s茅curit茅 et des avenants de pr锚t visant 脿 r茅duire les remboursements du capital jusqu'en avril 2026.

Nanalysis Scientific Corp. (OTCQX: NSCIF) meldete herausfordernde Ergebnisse f眉r das zweite Quartal 2025: Die Gesamtums盲tze fielen um 17% auf 9,6 Mio. USD. Der Produktabsatz ging deutlich um 46% auf 2,9 Mio. USD zur眉ck, w盲hrend die Erl枚se aus Sicherheitsdienstleistungen um 7% auf 5,6 Mio. USD stiegen.

Trotz r眉ckl盲ufiger Ums盲tze verbesserte das Unternehmen die Bruttomargen im Produktbereich deutlich auf 61% statt 50% im Jahresvergleich. Es wies ein bereinigtes EBITDA-Verlust von 462.000 USD aus gegen眉ber einem Gewinn von 759.000 USD im Q2 2024 und einen Nettoverlust von 2,1 Mio. USD.

Wesentliche Entwicklungen sind der Abschluss einer 2-Millionen-Dollar-Schuldverschreibung, Effizienzma脽nahmen im Bereich Sicherheitsdienstleistungen und Kredit盲nderungen zur Reduzierung der Tilgungszahlungen bis April 2026.

Positive
  • Product sales gross margin improved significantly to 61% from 50% year-over-year
  • Security services revenue grew 7% to $5.6 million
  • Successfully secured $2 million in financing through promissory notes
  • Obtained favorable loan amendments reducing principal payments and extending amortization to 2028
Negative
  • Total revenue declined 17% to $9.6 million year-over-year
  • Product sales dropped severely by 46% to $2.9 million
  • Adjusted EBITDA turned negative at -$462,000 versus +$759,000 in Q2 2024
  • Net loss increased to $2.1 million from $2.0 million year-over-year

CALGARY, AB, Aug. 28, 2025 /PRNewswire/ - ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1),听a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30, 2025.听Chief Executive Officer听Sean Krakiwsky听and Chief Financial Officer听Randall McRae听will host a conference call at听5 P.M. Eastern Time听today听to discuss the results. A second call will be held for European investors at听8:30 A.M. Eastern Time tomorrow, Friday, August 29th. All interested parties are invited to join these calls.听 All dollar figures in this press release are in thousands of Canadian dollars, except per share amounts or unless otherwise stated.听听 听

"The first half of 2025 has been challenging because of economic uncertainty caused by global tariff and trade conditions. The second quarter reflected lower product sales, which had a direct impact on our financial results," said Sean Krakiwsky, Founder and CEO of Nanalysis. "Even so, our cost reduction and efficiency measures have continued to support stronger margins in the scientific equipment business. In our security services segment, the team's focus on scheduling, logistics, and cost management has led to sequential margin improvement, and we expect these efforts will continue to benefit margins in the coming quarters.

"Our plan remains unchanged, we are focused on building a vertically integrated scientific instrumentation company, advancing our Benchtop NMR platforms, and strengthening our service business. Operational execution and efficiency will remain at the core of how we deliver results as we progress on the path to long-term profitable growth."

Financial highlights for the three months ended听June 30, 2025:



Three months ended June 30

($000'蝉)听


2025

2024

Change $

Change %

Product sales


2,902

5,402

(2,500)

-46听%

Security services revenue


5,617

5,265

352

7听%

Flow-through inventory revenue


1,057

807

250

31听%

Total sales and revenue


9,576

11,474

(1,898)

-17听%







Gross margin percentage - product sales


61听%

50听%

11听%


Gross margin percentage - service revenue


10听%

10听%

0听%








Adjusted EBITDA


(462)

759

(1,221)


Normalized net loss (excludes impairment of assets)


(2,122)

(1,795)

(327)

-18听%

Net loss


(2,122)

(1,995)

(127)

-6听%

  • For the three months ended June 30, 2025, the Company reported consolidated revenue of $9,576, a decrease of $1,898 or 17% from the comparative period in 2024. This decline was primarily driven by lower product sales, as ongoing global economic uncertainty and tariff risks continued to constrain customer capital budgets. Within the security services segment, revenue increased modestly by 7% year-over-year.
  • Gross margin percentage for the three-month period ended June 30, 2025, on product sales was 61%, versus 50% for the three-month period ended June 30, 2024. Continuous improvement efforts have resulted in significantly improved margins over the prior year.
  • Security service gross margin percentage in the quarter was 10%, the same as in the prior year comparative period. The Company has initiated improvements in its processes to better manage cost of security services, including better scheduling, improving logistics processes and managing overtime and on-call hours. This has resulted in an improvement in margins of 4% over Q1 2025, and the Company expects to continue seeing margins improve for the remainder of the year.
  • Adjusted EBITDA (loss) for the three months ended June 30, 2025, was ($462) versus an Adjusted EBITDA profit of $759 in the same period last year. This was primarily the result of a drop in scientific equipment sales in the quarter.
  • Net loss was $2,122 for the second quarter of 2025, which is $127 higher than the same period in 2024. The increase in net loss was due to lower revenues from scientific equipment sales offset by lower depreciation, stock-based compensation, and the fact that losses from associate are no longer recorded in the consolidated statement of loss and comprehensive loss due to the impairment of the Quad investment in 2024.

Financial highlights for the six months ended听June 30, 2025:



Six months ended June 30

($000'蝉)听


2025

2024

Change $

Change %

Product sales


6,589

9,618

(3,029)

-31听%

Security services revenue


10,640

9,988

652

7听%

Flow-through inventory revenue


2,941

3,030

(89)

-3听%

Total sales and revenue


20,170

22,636

(2,466)

-11听%







Gross margin percentage - product sales


64听%

49听%

15听%


Gross margin percentage - service revenue


8听%

9听%

-1听%








Adjusted EBITDA


(282)

655

(937)


Normalized net loss (excludes impairment of assets)


(3,429)

(4,317)

888

21听%

Net loss


(3,429)

(4,517)

1,088

24听%

  • The Company reported consolidated revenue of听$20,170, a decrease of $2,466听辞谤 11% from the comparative period in 2024. This is primarily the result of a $3,029 decrease in product sales, offset by a $652 increase in security services revenue.
  • Gross margin percentage on product sales was 64% for the six months ended听June 30, 2025, up from 49% in the prior year. Continuous improvement programs continue to support improvements in 2025 gross margins.
  • Gross margin percentage on service revenue was 8% for the six months ended听June 30, 2025, compared to 9% in 2024. The Company has reversed its margin decline from Q4 2024 and Q1 2025 and looks to continue growing margins for the rest of 2025.
  • Adjusted EBITDA loss for the six months ended听June 30, 2025, was听($282)听versus Adjusted EBITDA $655听for the same period last year. The drop was primarily due to a $3,029 decrease in product sales.

Quarterly Trend:






($000'蝉)听

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Product sales

2,902

3,687

5,536

4,242

Security services revenue

5,617

5,023

5,602

5,420

Flow-through parts revenue

1,057

1,884

1,151

908

Total revenue

9,576

10,594

12,289

10,570






Adjusted EBITDA

(462)

180

1,904

545






Normalized net loss

(2,122)

(1,307)

(400)

(1,570)

  • In Q2 2025, product sales were down by $785 from Q1 2025 mainly due to full quarter impacts of economic uncertainty and tariff risks. This has cooled markets for capital equipment globally and eliminated expected 2025 growth and, in fact, resulted in a decline in overall sales globally. This was offset by an increase in security service revenue of $594 due to increased labour hours as well as the realization of certain contractual service bonuses.

Recent strategic and operational highlights during and after the second quarter of 2025 include:

  • Margin Improvement in Security Services: Process and logistics improvements initiated in Q2 led to better scheduling and cost control in the Airport Security Maintenance Business, resulting in sequential gross margin improvement from Q1. This is expected to continue through the remainder of 2025, as our new EVP of Services begins to have an impact on improved operations.
  • Closed Promissory Note Financing: On June 12, 2025, the Company closed a fully subscribed private placement of unsecured promissory notes for gross proceeds of $2,000. The notes bear 12% annual interest, payable in cash or, in common shares of the Company. In connection with the financing, the Company issued 1,600,000 common shares at $0.25 per share to the lenders, representing 20% of the principal amount. Net proceeds will be used for general working capital purposes and to support ongoing operations.
  • Signed an amending agreement with its lender: During the period ending June 30, 2025, the Company signed an amending agreement with its lender, obtaining a reduction in its loan principal payment from May 31, 2025, to April 30, 2026, as well as an extension of its loan amortization to May 31, 2028.

Outlook

"As we move into the second half of 2025, we continue to see a solid sales funnel; however, the first half highlighted how tariff risks and broader economic conditions can influence the timing of capital equipment purchases," said Mr. Krakiwsky.

"In the Security Services segment, the team has been implementing efficiency measures introduced in the second quarter, with a focus on scheduling, logistics, and cost management. These efforts, together with ongoing cost control and working capital discipline, are directed at improving operational effectiveness.

"Across both product and services, our focus remains on efficiency, margin improvement, and the continued advancement of our Benchtop NMR platforms and service offerings. The team is committed to process improvements and execution, as we persevere through these difficult economic conditions" added Mr. Krakiwsky.

Conference Call:

Investors interested in participating in the live full year call can dial 437-900-0527 or 1-888-510-2154 from听abroad. Investors can also access the call online through a listen-only webcast here 听or on the investor relations section of the Company's website .

The webcast will be archived on the Company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID #83432.

Additionally, the Company will be hosting a Q&A session for its European investors at 8:30am ET tomorrow, Friday, August 听29th, which can be accessed by the following link: .

Non-IFRS and Supplementary Financial Measures

The Company prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, 鈥巃s adopted 鈥巄y the Canadian Accounting Standards Board ("IFRS"). However, this press release may make reference to certain non-IFRS measures including key 鈥巔erformance indicators used by management. These measures are not recognized measures under IFRS 鈥巃nd do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable 鈥巘o similar measures presented by other companies. Rather, these measures are provided as additional 鈥巌nformation to complement those IFRS measures by providing further understanding of the Company's results of 鈥巓perations from management's perspective. Accordingly, these measures should not be considered in 鈥巌solation nor as a substitute for analysis of the Company's financial information reported under IFRS.

The 鈥嶤ompany uses Flow-through parts revenue, Security services revenue, Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"), and Normalized net loss as non-IFRS measures, which may be calculated 鈥巇ifferently by other companies. These non-IFRS measure are used to provide investors supplemental measures of the Company's operating performance and liquidity and thus highlight trends in the Company's 鈥巄usiness that may not otherwise be apparent when relying solely on IFRS measures. The Company also 鈥巄elieves that securities analysts, investors and other interested parties frequently use non-IFRS measures 鈥巌n the evaluation of companies in similar industries.

Flow through parts revenue and Security services revenue



听Three months ended June 30听

($000'蝉)听


2025

2024

听($) Change听

Security services revenue


5,617

5,265

352

Flow-through inventory revenue


1,057

807

250

Total Service Revenue


6,674

6,072

602






Security services costs


5,065

4,759

306

Flow-through inventory costs


1,057

807

250

Total Cost of Services


6,122

5,566

556








听Six months ended June 30听

($000'蝉)听


2025

2024

听($) Change听

Security services revenue


10,640

9,988

652

Flow-through inventory revenue


2,941

3,030

(89)

Total Service Revenue


13,581

13,018

563






Security services costs


9,789

9,114

675

Flow-through inventory costs


2,941

3,030

(89)

Total Cost of Services


12,730

12,144

586

Adjusted EBITDA



听Three months ended June 30听

($000'蝉)听


2025

2024

听($) Change听

Net loss


(2,122)

(1,995)

(127)

Depreciation and amortization expense


1,051

1,154

(103)

Finance expense


359

357

2

Stock-based compensation


112

388

(276)

Other (income) expenses


(44)

350

(394)

Amortization of deferred wages


216

276

(60)

Loss from associate


-

235

(235)

Current income tax expense


10

2

8

Deferred income tax recovery


(44)

(8)

(36)

Adjusted EBITDA


(462)

759

(1,221)













听Six months ended June 30听

($000'蝉)听


2025

2024

听($) Change听

Net loss


(3,429)

(4,517)

1,088

Depreciation and amortization expense


1,975

2,306

(331)

Finance expense听


686

711

(25)

Stock-based compensation


243

648

(405)

Other (income) expenses


(182)

604

(786)

Amortization of deferred wages


406

466

(60)

Loss from associate


-

435

(435)

Current income tax expense听


37

34

3

Deferred income tax recovery


(18)

(32)

14

Adjusted EBITDA


(282)

655

(937)

Adjusted EBITDA by Quarter

($000'蝉)听

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Net loss

(2,122)

(1,307)

(7,452)

(1,644)

Depreciation and amortization expense

1,051

924

1,155

1,165

Finance expense

359

327

293

341

Stock-based compensation

112

131

199

181

Other (income) expenses

(44)

(138)

124

(94)

Amortization of deferred wages

216

190

215

214

Loss from associate

-

-

345

305

Impairment of assets

-

-

7,052

74

Current income tax expense (recovery)

10

27

33

(22)

Deferred income tax (recovery) expense

(44)

26

(60)

25

Adjusted EBITDA

(462)

180

1,904

545

Normalized net loss

($000'蝉)听

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Net loss

(2,122)

(1,307)

(7,452)

(1,644)

Impairment of assets

-

-

7,052

74

Normalized net loss

(2,122)

(1,307)

(400)

(1,570)

Supplementary Financial Measures听

The Company may also use supplementary financial measures which are intended to be disclosed on a periodic basis to depict the historical or expected future financial performance, cash position, or cash flow of the Company, are not a non-IFRS measure, and are not presented in the financial statements. The measures as discussed in this press release include:

  • Gross margin percentage, which is defined as either (Product sales less Cost of product sold) divided by Product sales or (Security services revenue less Security services costs) divided by Security services revenue

About (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis Scientific Corp. is a scientific instrumentation company with proprietary products and services groups working synergistically. The Company is a leading developer and supplier of cryogen-free portable Nuclear Magnetic Resonance (NMR) spectrometers, with a family of proprietary products that sell around the world in the pharma, biotech, energy, food, chemical, advanced materials, and security verticals, as well as in universities and government labs. Whether it is a new drug being developed, a lithium brine pool sample, polymer analysis, or assessing adulteration in foods, customers use the company's products to identify molecular structure. The Company's products are patent protected and manufactured in-house to protect intellectual property and optimize quality and costs. The Company leverages its technology by selling hardware and software on an original equipment manufacturer (OEM) basis to medical imaging customers. The Company provides services to its customers on its proprietary products, as well as on third-party imaging equipment, such as x-ray scanners in airports, border crossings, consulates, and correctional facilities. In 2022, the company won a $160 million services contract with the Canadian Air Transport Security Authority (CATSA) to service scanning equipment in over 80 Canadian airports: After three years of ramping up, the contract is profitable, and the Company continues to expand its services business.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:

SOURCE Nanalysis Scientific Corp.

FAQ

What were Nanalysis Scientific's (NSCIF) key financial results for Q2 2025?

Nanalysis reported total revenue of $9.6 million (down 17%), with product sales of $2.9 million (down 46%) and security services revenue of $5.6 million (up 7%). The company posted an Adjusted EBITDA loss of $462,000 and a net loss of $2.1 million.

How did Nanalysis's gross margins perform in Q2 2025?

Product sales gross margin improved significantly to 61% from 50% year-over-year, while security services gross margin remained stable at 10%.

What financing activities did NSCIF complete in Q2 2025?

Nanalysis closed a $2 million private placement of unsecured promissory notes bearing 12% annual interest and issued 1.6 million common shares at $0.25 per share to lenders.

What are the main challenges affecting Nanalysis's business in 2025?

The company faces challenges from economic uncertainty, global tariff and trade conditions, and constrained customer capital budgets, particularly affecting product sales performance.

What operational improvements is Nanalysis implementing to address current challenges?

The company is focusing on cost reduction, efficiency measures, improved scheduling and logistics in security services, and working capital discipline to enhance operational effectiveness and margins.
Nanalysis Sci

OTC:NSCIF

NSCIF Rankings

NSCIF Latest News

NSCIF Stock Data

18.33M
108.29M
3.92%
8.54%
Scientific & Technical Instruments
Technology
Canada
Calgary